BBNXBeta Bionics, Inc.
Surgical & Medical Instruments & Apparatus
- Revenue
- $100M
- 54% YoY
- Operating margin
- -71.5%
- 2.9% YoY
- EBITDA
- −$70M
- 59% YoY
- Market cap
- $911M
- Employees
- 420
- $239K revenue each
- Net debt / EBITDA
- —
- AI in 10-K
- 3.2
- mentions per 10K words
Takeover score 3 of 13
Fixable underperformance 1 of 7
- TSR below peersNo—3+ of last 5 years
- High CEO pay despite TSRNo—Median CEO pay ≥ $15M while TSR trails
- Earnings not backed by cashNo—Cash flow under 80% of net income
- Dilutive SBCYes16% of revenueOver 10% of revenue
- Payouts exceed cash flowNo0% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyNo—Over 40% of assets
- Shareholder dissentNo83% lowest supportAny vote under 80% support
Buyer economics 2 of 4
- Low revenue per employeeYes$239K · 19th pctBottom quartile of its SIC industry
- Quiet on AINo3.2 per 10K words · 71st pctBottom quartile of AI mentions in 10-Ks
- Net cashNo—More cash than debt, positive EBITDA
- Buyout-sizedYes$911M market capMarket cap $500M–$5B
Catalysts 0 of 2
- Active 13DNo0 filingsActive-intent 13D in 18 months
- Net insider sellingNo−$5M netNet sales over $10M in 12 months
Financials
| Metric | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|
| Revenue | $12M | $65M | $100M | 54% |
| Operating income | −$36M | −$45M | −$72M | 58% |
| Net income | −$44M | −$55M | −$73M | 34% |
| Operating cash flow | −$32M | −$48M | −$51M | 5.5% |
| Capex | $402K | $3M | $5M | 56% |
| Stock-based comp | $6M | $6M | $16M | 157% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $5M · 49
- Net
- −$5M
Pay vs performance
No pay-versus-performance disclosure yet.